Article info
PDFReview
Can I treat this pregnant patient with botulinum toxin?
- Correspondence to Catharine Sarah Pearce, 9 Baring Crescent, Exeter, Devon EX1 1TL, UK; pearcecs{at}cardiff.ac.uk
Citation
Can I treat this pregnant patient with botulinum toxin?
Publication history
- First published January 3, 2014.
Online issue publication
January 22, 2014
Article Versions
- Previous version (3 January 2014).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial
- What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport®
- British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin
- Factors affecting the health - related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double - blind, placebo - controlled study
- Problems with botulinum toxin treatment in mitochondrial cytopathy: case report and review of the literature
- Abnormal plasticity of sensorimotor circuits extends beyond the affected body part in focal dystonia
- Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia
- Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia
- A botulinum toxin A treatment algorithm for de novo management of torticollis and laterocollis
- Oropharyngeal swallowing in craniocervical dystonia